Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples